These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17334399)

  • 21. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.
    Zhong Z; Yeow WS; Zou C; Wassell R; Wang C; Pestell RG; Quong JN; Quong AA
    Cancer Res; 2010 Mar; 70(5):2105-14. PubMed ID: 20179208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
    Wilcken NR; Prall OW; Musgrove EA; Sutherland RL
    Clin Cancer Res; 1997 Jun; 3(6):849-54. PubMed ID: 9815758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis.
    Jirawatnotai S; Sharma S; Michowski W; Suktitipat B; Geng Y; Quackenbush J; Elias JE; Gygi SP; Wang YE; Sicinski P
    Cell Cycle; 2014; 13(18):2889-900. PubMed ID: 25486477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation.
    Mukhopadhyay A; Banerjee S; Stafford LJ; Xia C; Liu M; Aggarwal BB
    Oncogene; 2002 Dec; 21(57):8852-61. PubMed ID: 12483537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide.
    Park YG; Park S; Lim SO; Lee MS; Ryu CK; Kim I; Cho-Chung YS
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1213-9. PubMed ID: 11243864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA
    Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ClC-3 chloride channel protein is a downstream target of cyclin D1 in nasopharyngeal carcinoma cells.
    Zhang H; Zhu L; Zuo W; Luo H; Mao J; Ye D; Li Y; Liu S; Wei Y; Ye W; Chen L; Wang L
    Int J Biochem Cell Biol; 2013 Mar; 45(3):672-83. PubMed ID: 23270726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
    Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
    Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
    Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
    Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
    Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.
    Zhang T; Liu WD; Saunee NA; Breslin MB; Lan MS
    J Biol Chem; 2009 Feb; 284(9):5574-81. PubMed ID: 19124461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The roles of activated protein-1 and cell cycle protein in silica-induced cell cycle changes].
    Jia XW; Liu BC; Ye M; Liu HF; Zhang FM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Nov; 29(11):812-5. PubMed ID: 22357515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S; Barnes CJ; Rayala SK; Kumar R
    FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.